Identifying Electrophysiological Targets for Transcranial Magnetic Stimulation in Cocaine Use Disorder

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorThe University of Texas Health Science Center, Houston

About this trial

The purpose of this study is to assess effects of intermittent theta burst stimulation (iTBS) to left dorsolateral prefrontal cortex (dlPFC) and dorsomedial prefrontal cortex (dmPFC) compared to sham on electrophysiological indices of reward sensitivity and motivated attention in adults with cocaine use disorder.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

non-treatment-seeking adults

meet Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 criteria for current cocaine use disorder of at least moderate severity (≥ 4 symptoms)

have at least 1 positive urine Benzoylecgonine (BE) specimen (≥ 300 ng/mL) during intake

be able to understand the consent form and provide written informed consent

Disqualifiers

current DSM-5 diagnosis for substance use disorder (of at least moderate severity) other than cocaine, marijuana, or nicotine

in the opinion of the principal investigator (PI), the presence of any medical, neurological, psychiatric, or physical condition, disease, or illness that, may: (a) compromise interfere, limit, effect or reduce the subject's ability to complete the study; or (b) adversely impact the safety of the subject or the integrity of the data

Structured Clinical Interview for DSM-5 (SCID-5)

Columbia Suicide Severity Rating Scale (C-SSRS) Screener - Answers YES to Questions 3, 4, 5, or 6

Trial design

Design model

Crossover

Treatments tested in this trial

  • TMS to dmPFC

    Device

    TMS will be delivered with a MagVenture Mag Pro R30 with the Cool-B70 A/P coil with active liquid cooling and active/sham sides. For dmPFC, approximately 25% of the nasion-inion distance or Talairah coordinates X 0 Y+60 Z+60 will be measured. The first session will begin with the acquisition of the resting motor threshold (rMT) on the contralateral hand. iTBS (triplet 50 Hz bursts, repeated at 5 Hz, 2 sec on and 8 sec off; 600 pulses per session) will be delivered at 110% of the rMT and will last \~3 minutes. The stimulation will start at a lower percentage and ramp up over time to acclimate participant to the feeling of stimulation. The intensity will be lowered in participant cannot tolerate the stimulation. Each participant will receive 3 sessions per visit with a 15-20 minute interval between sessions to increase the likelihood of detecting acute effects.

  • TMS to dlPFC

    Device

    TMS will be delivered with a MagVenture Mag Pro R30 with the Cool-B70 A/P coil with active liquid cooling and active/sham sides. For dlPFC, position F3 will be measured, using probabilistic EEG placement. The first session will begin with the acquisition of the resting motor threshold on the contralateral hand. iTBS (triplet 50 Hz bursts, repeated at 5 Hz, 2 sec on and 8 sec off; 600 pulses per session) will be delivered at 110% of the rMT and will last 3 minutes. The stimulation will start at a lower percentage and ramp up over time to acclimate participant to the feeling of stimulation. The intensity will be lowered in participant cannot tolerate the stimulation. Each participant will receive 3 sessions per visit with a 15-20 minute interval between sessions to increase the likelihood of detecting acute effects.

  • Sham iTBS

    Device

    Sham TMS will be delivered with the sham side of the MagVenture Cool B70 A/P coil. The software will be pre-programmed by a staff member that will not be involved in data analysis or collection for blinding purposes. The sham stimulation will match the number of pulses and length of time as the active condition and each participant will receive 3 sessions with a 15-20 min interval between sessions.

Treatment groups

75 Participants
are divided into 6 treatment groups

6

Treatment groups

See each treatment group below.

Group A: dlPFC then dmPFC then Sham iTBSExperimental treatment 3 interventions
Group B: dmPFC then dlPFC then sham iTBSExperimental treatment 3 interventions
Group C: dmPFC then sham iTBS then dlPFCExperimental treatment 3 interventions
Group D: dlPFC then sham iTBS then dmPFCExperimental treatment 3 interventions
Group E: sham iTBS then dlPFC then dmPFCExperimental treatment 3 interventions
Group F: shami iTBS then dmPFC then dl PFCExperimental treatment 3 interventions

Trial outcomes

Primary outcomes

1

Change in the amplitude of the Reward Positivity (RewP) component in microvolts in response to feedback on the Doors Task

The Doors Task will be used to elicit the RewP component, representing reward sensitivity. The task is a guessing game, where participants guess which door contains a reward behind it. After selecting a door, the participants are notified if they found the prize by a green arrow pointing up or if they did not find the prize by a red arrow pointing down.

Time frame
Baseline(before iTBS session),immediately after iTBS session
2

Change in the amplitude of the Late Positive Potential (LPP) in microvolts in response to visual stimuli on the Picture Viewing Task.

The Picture Viewing Task will be used to elicit the LPP, reflecting the motivational salience of a stimulus. During this task, participants are asked to view a slide show of images including pleasant, unpleasant, neutral, and cocaine-related images.

Time frame
Baseline(before iTBS session),immediately after iTBS session

Secondary outcomes

1

Change in craving as assessed by the Minnesota Cocaine Craving Scale (MCCS)

The intensity of craving score will be used, scored from 1(none at all) to 10 (a great deal).

Time frame
Baseline(before iTBS session),immediately after iTBS session
2

Change in pain as assessed by the Visual Analogue Scale

This is scored from 1(no pain) to 10 (worst pain)

Time frame
Baseline(before iTBS session),immediately after iTBS session
3

Change in cognitive function as assessed by the The Montreal Cognitive Assessment (MoCA)

Total score on the Montreal Cognitive Assessment (MoCA) range from 0 to 30, with a higher score indicating a better outcome.

Time frame
Baseline(before iTBS session),immediately after iTBS session
4

Change in behavioral reward learning as assessed by the Pavlovian Go/No-Go task

In the first "learning" phase, participants learn whether to press a button or withhold a response to receive a monetary reward or avoid a loss. In the second "transfer" phase, participants perform a forced choice task, where each of the predictive cues in the learning phase are paired with each other. Participants must select the "most rewarding" cue.

Time frame
Baseline(before iTBS session),immediately after iTBS session

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

The University of Texas Health Science Center, Houston

Lead sponsor

National Institute on Drug Abuse (NIDA)

Collaborator